GURU.Markets stock price, segment price, and overall market index valuation
The company's share price INVO Bioscience Inc.
Inozyme is a biotech company developing drugs to treat rare genetic diseases associated with vascular mineralization. Its stock price is highly volatile and depends entirely on the results of clinical trials.
Share prices of companies in the market segment - Specialized medical equipment
INVO Bioscience has developed the INVOcell medical device, which allows for the incubation of fertilized eggs inside a woman's body, making IVF more accessible. We've classified it as "Specialized Medical Equipment." The graph below shows the developments in the reproductive medicine sector.
Broad Market Index - GURU.Markets
INVO Bioscience is a medical company that has developed an accessible and less invasive in vitro fertilization (IVF) procedure. As an innovator, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with INVO's performance to assess the state of this sector.
Change in the price of a company, segment, and market as a whole per day
INVO - Daily change in the company's share price INVO Bioscience Inc.
For INVO Bioscience, Inc., a fertility treatment company, daily volatility reflects the sensitivity to the adoption of its technology. This metric is an indicator of demand for more affordable IVF solutions.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
INVO Bioscience offers a more affordable solution for infertility treatment—the INVOcell incubation system. The reproductive medicine market is growing but sensitive to innovation. The chart below shows the volatility in the medical device sector, helping to assess how the market is responding to INVO's technology.
Daily change in the price of a broad market stock, index - GURU.Markets
INVO Bioscience offers more affordable infertility treatments. This medtech company's stock price reflects the demand for reproductive services, which is driven by demographic and social trends. Its share price reflects the contribution of innovative medicine to overall market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization INVO Bioscience Inc.
For INVO Bioscience, the year-over-year trend is a story of its unique approach to infertility treatment. Its market capitalization growth over the past 12 months reflects its success in promoting its INVOcell® system, which allows for the incubation of embryos inside a woman's body, offering a more affordable and natural alternative to traditional IVF.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
INVO Bioscience, Inc. offers a more affordable solution for infertility treatment. Its technology has the potential to disrupt the traditional IVF market. This chart shows how its innovative yet niche strategy and market expansion efforts are impacting its volatile performance in the medtech sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
INVO Bioscience, a company offering a more accessible and simpler IVF technology, operates in the infertility treatment market. Its annual market capitalization growth reflects the success of its method among clinics and patients. This is a story about how innovation can democratize access to healthcare.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization INVO Bioscience Inc.
INVO is a medical company offering an affordable IVF solution. Its monthly growth is driven by the implementation of its INVOcell technology in fertility clinics. News about the expansion of its clinic network and the increase in the number of procedures are the main drivers.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
This chart illustrates the dynamics of the medical technology sector, particularly in the field of infertility treatment. For INVO, with its affordable solution, this provides context. Its movements reflect demand for its technology and its success in expanding its network of partner clinics.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
INVO Bioscience has developed and is commercializing a more affordable method of in vitro fertilization (IVF) using its INVOcell device. The company's success depends on the adoption of its technology. A full-market chart helps assess how INVO's stock, as a medtech company, is influenced by its own news, rather than by overall market sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization INVO Bioscience Inc.
INVO Bioscience has developed a device for incubating fertilized eggs inside a woman's body, offering a more affordable IVF method. Its weekly stock price is dependent on the adoption of this technology in clinics and regulatory approvals.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
INVO Bioscience offers a more affordable method of in vitro fertilization (IVF). The company aims to make infertility treatment more accessible. The chart will show whether INVO's stock price is reflecting the introduction of its technology into clinics or following general trends in the reproductive health services sector.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
INVO Bioscience is a company in the infertility treatment field. It's a niche growth story. The chart below shows how its stock, driven by the introduction of new technology, is more volatile and outperforms the broader market.
Market capitalization of the company, segment and market as a whole
INVO - Market capitalization of the company INVO Bioscience Inc.
INVO Bioscience's market capitalization dynamics reflect a speculative bet on its unique infertility treatment device, which allows fertilization to occur inside a woman's body. Its low valuation and volatile price chart reflect the challenges of commercializing this technology and competing with traditional IVF.
INVO - Share of the company's market capitalization INVO Bioscience Inc. within the market segment - Specialized medical equipment
INVO Bioscience has developed a medical device to make IVF more accessible. Its market share in assisted reproductive technologies is small, but it offers an innovative and less expensive alternative. The chart shows how the market perceives its potential to transform the infertility treatment industry.
Market capitalization of the market segment - Specialized medical equipment
The graph below shows the overall value of the medical device sector. INVO Bioscience is a unique player that has developed a more accessible and natural method of infertility treatment. The dynamics of this market reflect the huge demand for IVF services. INVO strives to democratize this process by offering its innovative and cost-effective technology.
Market capitalization of all companies included in a broad market index - GURU.Markets
INVO Bioscience has developed the INVOcell medical device, which makes IVF procedures simpler and more accessible. Its market capitalization is driven by this technology. The chart below shows the economic weight of companies making infertility treatment more accessible.
Book value capitalization of the company, segment and market as a whole
INVO - Book value capitalization of the company INVO Bioscience Inc.
INVO Bioscience's book value is derived from its intellectual property rights to the INVOcell device, which enables the incubation of oocytes and sperm inside a woman's body, making IVF more accessible. The chart tells the story of a medical company attempting to commercialize its unique and simpler fertility treatment technology.
INVO - Share of the company's book capitalization INVO Bioscience Inc. within the market segment - Specialized medical equipment
INVO Bioscience has developed a more affordable IVF method. The chart shows its share of real assets. These are its manufacturing facilities, where INVOcell devices, the physical embodiment of its innovative technology, are produced.
Market segment balance sheet capitalization - Specialized medical equipment
INVO Bioscience has developed a more affordable method of in vitro fertilization (IVF). Their business requires the production of specialized medical devices. The book value chart shows the value of their manufacturing and R&D assets in this sensitive medical area.
Book value of all companies included in the broad market index - GURU.Markets
INVO Bioscience's resources include laboratories and manufacturing facilities for developing their device for intrauterine embryo incubation, an alternative to traditional IVF. The chart shows how the technology's production capacity has grown.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - INVO Bioscience Inc.
INVO Bioscience offers a more affordable solution for infertility treatment. Its value lies in its patented technology. The chart below is a bet that its method will become a popular alternative to expensive IVF. The market valuation reflects its growth potential in the vast reproductive medicine market.
Market to book capitalization ratio in a market segment - Specialized medical equipment
INVO Bioscience has developed a medical device, INVOcell, that allows for the incubation of embryos inside a woman's body, making IVF more accessible. Its value lies in this unique technology. The chart shows how the market perceives its commercial potential and its potential to transform the reproductive technology market.
Market to book capitalization ratio for the market as a whole
INVO Bioscience has developed an alternative to traditional IVF. The company's value lies in its patented technology and growth potential in the reproductive medicine market. This metric demonstrates the premium investors pay for an innovative approach over modest tangible assets.
Debts of the company, segment and market as a whole
INVO - Company debts INVO Bioscience Inc.
INVO Bioscience has developed a medical device that enables the incubation of embryos inside a woman's body (intravaginal culture). This chart shows the company's financial strategy for commercializing its unique and more accessible technology for infertility treatment.
Market segment debts - Specialized medical equipment
INVO Bioscience has developed an alternative IVF method that is more accessible. Commercializing a new medical procedure requires not only approval but also training physicians and creating a market. This chart shows the company's financial strategy for widespread adoption of its technology.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio INVO Bioscience Inc.
INVO Bioscience has developed a medical device for infertility treatment. This chart shows its financial structure. Financial strength is crucial for a company bringing a new medical technology to market. High debt could become a problem if market adoption is delayed.
Market segment debt to market segment book capitalization - Specialized medical equipment
INVO Bioscience has developed a more affordable in vitro fertilization (IVF) method. This chart shows the debt burden in the medical device sector. It helps understand how the company is funding the commercialization of its unique technology and striving to make infertility treatment more accessible.
Debt to book value of all companies in the market
INVO Bioscience offers a more affordable infertility treatment. Commercializing new medical procedures requires investment in marketing and physician training. This graph of total market debt helps understand how favorable the overall financial environment is for raising capital for such innovative companies in the healthcare sector.
P/E of the company, segment and market as a whole
P/E - INVO Bioscience Inc.
INVO Bioscience has developed and commercialized the INVOcell device, which enables the incubation of eggs and sperm inside a woman's body, offering a more affordable alternative to traditional IVF. This chart shows how investors are evaluating this innovative fertility treatment technology.
P/E of the market segment - Specialized medical equipment
INVO Bioscience developed and commercialized the INVOcell device, which allows for the incubation of eggs and sperm inside a woman's body, offering a more natural and accessible method of IVF. This chart shows the average valuation for the specialized medical equipment sector, reflecting how investors view innovations that make infertility treatments more accessible.
P/E of the market as a whole
INVO Bioscience has developed a medical device that allows for the incubation of fertilized eggs inside a woman's body, offering a more affordable alternative to IVF. Its evaluation is a bet on this unique technology. It is not tied to general economic cycles but depends on its acceptance by doctors and patients.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company INVO Bioscience Inc.
INVO Bioscience is a medical company that developed the INVOcell device, which enables embryo incubation inside a woman's body, making IVF more accessible. This graph reflects expectations for the commercialization of this technology. Future profits depend on its adoption in reproductive medicine.
%20P%2FE%20INVO%20Bioscience%20Inc.&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-INVO-Bioscience-Inc.&v=1772587218113 "Chart of the company's future (projected) P/E INVO Bioscience Inc.")
Future (projected) P/E of the market segment - Specialized medical equipment
INVO Bioscience is developing and commercializing the INVOcell device, which enables the incubation of eggs and sperm inside a woman's body, offering a more affordable IVF method. This chart shows general expectations for the medical device sector. INVO's position relative to the average reflects investors' confidence in the potential of this innovative technology.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772587218119 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
INVO Bioscience has developed and commercialized the INVOcell device, which enables the incubation of eggs and sperm inside a woman's body. This is a more affordable and natural method of infertility treatment compared to traditional IVF. This graph of general market expectations provides a backdrop for evaluating innovative medical technologies in the vast reproductive health market.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772587218152 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit INVO Bioscience Inc.
INVO Bioscience has developed a medical device, INVOcell, which allows for part of the in vitro fertilization (IVF) process to be performed inside a woman's body. Its financial outlook reflects its efforts to commercialize this more accessible fertility treatment technology.
Profit of companies in the market segment - Specialized medical equipment
INVO Bioscience has developed and commercialized the INVOcell device, which enables the incubation of eggs and embryos inside a woman's body, making IVF more accessible. This graph shows the collective profitability of the specialized medical equipment sector. It illustrates the success and profitability of companies offering innovative and more accessible solutions in reproductive medicine.
Overall market profit
INVO Bioscience has developed a medical device that allows for the incubation of embryos inside a woman's body, offering an alternative to traditional IVF. The company's success depends on the acceptance of this technology by doctors and patients. General economic cycles, as illustrated in this graph, can impact families' ability to afford expensive fertility treatments.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company INVO Bioscience Inc.
INVO Bioscience has developed a medical device, INVOcell, which allows for the incubation of fertilized eggs within a woman's body, offering a more affordable alternative to IVF. This graph reflects analysts' expectations for the commercial success of this innovative technology in reproductive medicine.
%20profit%20of%20the%20company%20INVO%20Bioscience%20Inc.&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-INVO-Bioscience-Inc.&v=1772587218227 "Graph of future (projected) profit of the company INVO Bioscience Inc.")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
INVO Bioscience has developed the INVOcell medical device, which allows for the incubation of fertilized eggs inside a woman's body, offering a more affordable alternative to traditional IVF. This chart shows forecasts for the medical device sector, helping to assess how INVO's innovation could change the infertility treatment market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772587218234 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
INVO Bioscience has developed a medical device for infertility treatment. Demand for such procedures depends on demographic trends and patient affordability, as they are often not covered by insurance. This trend, reflecting the state of the economy, influences people's willingness to spend significant amounts on treatment.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772587218274 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - INVO Bioscience Inc.
INVO Bioscience offers a more accessible and simple solution for infertility treatment (the INVOcell procedure). This chart shows how investors view its attempt to disrupt the traditional IVF market. The trend reflects the belief that its technology will be accepted by clinics and patients as an effective and cost-effective alternative.
P/S market segment - Specialized medical equipment
INVO Bioscience developed the INVOcell medical device, which enables the incubation of eggs and sperm inside a woman's body, making IVF more accessible. Revenue comes from sales of this device. This chart for the medical equipment sector helps assess how investors see the potential of INVO's technology to transform the assisted reproductive technology market.
P/S of the market as a whole
INVO Bioscience has developed the INVOcell medical device, which enables the incubation of eggs and sperm inside a woman's body, making IVF a simpler and more accessible method. This market revenue valuation chart helps understand how investors view the company's potential to make fertility treatment more accessible.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company INVO Bioscience Inc.
INVO Bioscience has developed and commercialized the INVOcell device—an affordable and less invasive infertility treatment that allows fertilization and early embryo development to occur inside a woman's body. This chart shows how investors estimate the future sales of this innovative IVF technology.
%20P%2FS%20INVO%20Bioscience%20Inc.&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-INVO-Bioscience-Inc.&v=1772587218323 "The graph of the company's future (projected) P/S INVO Bioscience Inc.")
Future (projected) P/S of the market segment - Specialized medical equipment
INVO Bioscience has developed and commercialized the INVOcell device, which enables the incubation of eggs and embryos inside a woman's body, offering a more affordable alternative to traditional IVF. The company's valuation reflects the potential of its technology to expand access to infertility treatment, but also the challenges of its widespread adoption.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772587218330 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
INVO Bioscience has developed a device that enables fertilization and early embryo development inside a woman's body. This is an innovative approach to infertility treatment. In the context of the overall revenue projections shown in the chart, INVO exemplifies technological advancement in medicine.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772587218368 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales INVO Bioscience Inc.
INVO Bioscience develops and commercializes the INVOcell device, which is used to incubate eggs and sperm inside a woman's body during IVF. This chart shows revenue from sales of this device and disposable components to fertility clinics.
Sales of companies in the market segment - Specialized medical equipment
INVO Bioscience (INVO) has developed and is commercializing the INVOcell device—an affordable and effective infertility treatment that utilizes fertilization and early embryo incubation within the woman's body. This figure reflects the revenues of the medical device market. INVO's technology has the potential to make IVF more accessible to millions of couples worldwide.
Overall market sales
INVO Bioscience has developed a medical device for incubating oocytes and embryos in vivo (inside a woman's body), offering a more affordable IVF method. Demand for its technology depends on the infertility treatment market. This overall economic activity affects patients' ability to afford these procedures, which are often not fully covered by insurance.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company INVO Bioscience Inc.
INVO Bioscience has developed the INVOcell medical device, which enables the incubation of fertilized eggs within a woman's body, making IVF more accessible. Future revenue depends on the adoption of this technology by clinics and patients. This chart reflects analyst sales forecasts, which are a bet on the success of this innovative approach in reproductive medicine.
%20sales%20of%20the%20company%20INVO%20Bioscience%20Inc.&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-INVO-Bioscience-Inc.&v=1772587218460 "Schedule of future (projected) sales of the company INVO Bioscience Inc.")
Future (projected) sales of companies in the market segment - Specialized medical equipment
INVO Bioscience is developing and commercializing a medical device for infertility treatment. This graph shows the potential future revenue from sales of their device and the opening of clinics. This is an analyst's perspective on the commercial prospects of their more accessible approach to in vitro fertilization.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772587218465 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
INVO Bioscience has developed and commercialized the INVOcell device, which enables embryo incubation within a woman's body, making IVF more accessible. This graph shows overall healthcare costs, and the adoption of INVO's technology is an indicator of demand for cheaper and more accessible infertility treatments.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772587218466 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality INVO Bioscience Inc.
INVO Bioscience has developed a medical device, INVOcell, that allows for part of the IVF process to be performed within a woman's body. The company's profitability depends on the adoption of this more accessible and natural technology by clinics and patients. The chart shows the financial trajectory of the company, which aims to transform the infertility treatment market.
Market segment marginality - Specialized medical equipment
INVO Bioscience is a medical company that developed the INVOcell device, which enables fertilization and early embryo development inside a woman's body, offering a more affordable alternative to traditional IVF. This chart shows the company's path to profitability. Success depends on the adoption of this technology in fertility clinics.
Market marginality as a whole
INVO Bioscience has developed a medical device for a more accessible and natural IVF procedure. Demand for its technology depends on the willingness of clinics and patients to use it. This overall profitability chart reflects the financial situation of consumers. During periods of economic growth, people can afford expensive infertility treatments.
Employees in the company, segment and market as a whole
Number of employees in the company INVO Bioscience Inc.
INVO Bioscience has developed the INVOcell medical device, which offers a more affordable and natural method of infertility treatment. This graphic shows the small team working to commercialize this innovative technology, aiming to help more couples realize their dream of having a child.
Share of the company's employees INVO Bioscience Inc. within the market segment - Specialized medical equipment
INVO Bioscience offers a more accessible and simple solution for infertility treatment (INVOcell technology). As a medical technology company, its staff consists of specialists in R&D, clinical management, and physician training. This chart shows the human resources the company is devoting to making IVF more accessible to patients.
Number of employees in the market segment - Specialized medical equipment
INVO Bioscience has developed a medical device for a more natural and accessible IVF process. This chart, which shows employment in the specialized medical equipment sector, demonstrates the growing demand for reproductive technologies. For INVO, the growing number of fertility clinics means an expanding potential market for their innovative system.
Number of employees in the market as a whole
INVO Bioscience has developed a medical device that allows embryo incubation directly within a woman's body, making IVF more accessible. Demand for such services depends on income. The increase in overall employment, shown in this graph, means more couples can afford expensive fertility treatments.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company INVO Bioscience Inc. (INVO)
INVO Bioscience (INVO) offers infertility treatment technology (the INVOcell device). It is a niche MedTech. This metric reflects how the market perceives their unique, patented technology and its potential in the IVF market. Value is created by R&D and B2B marketing, not a large staff.
%20of%20the%20company%20INVO%20Bioscience%20Inc.%20(INVO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-INVO-Bioscience-Inc.-INVO&v=1772587218773 "Chart of market capitalization per employee (in thousands of dollars) of the company INVO Bioscience Inc. (INVO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
INVO Bioscience has developed a more accessible method of in vitro fertilization (IVF). In the MedTech sector, this figure reflects how the market perceives the potential of its unique technology to make infertility treatment more accessible to millions of people worldwide.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772587218802 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
INVO Bioscience has developed the INVOcell medical device, which allows for part of the IVF process to be performed within a woman's body. This is an innovation in reproductive medicine. This chart from INVO Bioscience demonstrates how a unique medical device, making treatment more accessible, can generate significant market value with the help of a small team.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772587218808 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company INVO Bioscience Inc. (INVO)
INVO Bioscience has developed a device for simpler and cheaper IVF (INVOcell). They are a small medical technology company trying to disrupt the infertility treatment market. This graph shows their success in commercializing their niche product. High return on investment (ROI) will indicate successful implementation of their technology in clinics.
%20Chart%20INVO%20Bioscience%20Inc.%20(INVO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-INVO-Bioscience-Inc.-INVO&v=1772587218828 "Company Profit Per Employee (in thousands of dollars) Chart INVO Bioscience Inc. (INVO)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
INVO Bioscience has developed a medical device that allows for one stage of IVF to be performed inside a woman's body. In the reproductive technology niche, the effectiveness of a small team promoting an innovative product is crucial. This metric demonstrates how the company utilizes its resources to commercialize a unique technology and the financial return it achieves.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772587218908 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
INVO Bioscience is a medical technology company that developed the INVOcell device. It offers a more accessible and simpler IVF method, allowing fertilization to occur inside the body. This graph shows the average economic profitability per employee. It helps investors understand the potential of the medical technology sector, where patents and partnerships with clinics are crucial, to generate high added value.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772587218925 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee INVO Bioscience Inc. (INVO)
INVO Bioscience has developed the INVOcell medical device, which enables the incubation of eggs and sperm inside a woman's body, making IVF more accessible. Revenue per employee reflects the early commercialization of this technology. The chart shows how the company is advancing its innovative and affordable infertility treatment.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-INVO-Bioscience-Inc.-INVO&v=1772587218969 "Sales chart per company employee INVO Bioscience Inc. (INVO)")
Sales per employee in the market segment - Specialized medical equipment
INVO Bioscience (INVO) develops and commercializes the INVOcell device, a more affordable method of assisted reproductive technology (IVF). This chart shows the average revenue per employee in the segment. It helps evaluate how effectively INVO generates sales of its niche medical device compared to its competitors.
Sales per employee for the market as a whole
INVO Bioscience (INVO) has developed INVOcell, a medical device that makes IVF (in vitro fertilization) procedures simpler and more accessible. The company is currently in the commercialization phase. This figure demonstrates how successfully the company is selling its unique device and related services to fertility clinics, given its small staff.
Short shares by company, segment and market as a whole
Shares shorted by company INVO Bioscience Inc. (INVO)
INVO Bioscience (INVO) is a company promoting the INVOcell device, a more affordable method of assisted reproduction (IVF). It's a micro-cap in a niche market. This chart shows short interest. The high bearish rates reflect investor doubts that this technology can compete with traditional IVF, as well as concerns about high cash burn. (346)
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-INVO-Bioscience-Inc.-INVO&v=1772587219095 "Short Shares Chart for the Company INVO Bioscience Inc. (INVO)")
Shares shorted by market segment - Specialized medical equipment
INVO Bioscience (INVO) offers a more affordable solution for infertility treatment (IVF) using its INVOcell device. The chart below shows the overall short position in the medical device sector. It reflects investors' skepticism about the speed of adoption of new reproductive technologies.
Shares shorted by the overall market
INVO Bioscience offers more affordable IVF technology. It's a niche medical technology. This chart measures general fear. When investors fear a recession, they expect consumers to postpone expensive, non-emergency medical procedures (like IVF). This threatens INVO's growth plans, as their clients become extremely price-sensitive.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator INVO Bioscience Inc. (INVO)
INVO Bioscience offers a more affordable solution for infertility treatment (INVOcell technology). It's a niche MedTech. This indicator measures the "temperature" of their commercialization. It "warms up" on news of new clinic openings or approval of their technology and "cools down" in anticipation of revenue growth.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-INVO-Bioscience-Inc.-INVO&v=1772587219230 "RSI 14 indicator chart for the company's stock INVO Bioscience Inc. (INVO)")
RSI 14 Market Segment - Specialized medical equipment
INVO Bioscience is a medical technology company that developed the INVOcell. This device enables fertilization and early embryo development inside a woman's body, offering a more affordable alternative to IVF. This chart tracks the collective sentiment in the specialized medical device sector, helping to assess how investors view this unique niche.
RSI 14 for the overall market
INVO Bioscience (INVO) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic poses the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast INVO (INVO Bioscience Inc.)
INVO Bioscience is a medical technology company that created the INVOcell, a device that makes IVF more accessible by allowing fertilization to occur inside the body rather than in a lab. This chart shows the speculative average 12-month price target from analysts, based on their belief in the adoption of this technology in IVF clinics.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-INVO-INVO-Bioscience-Inc.&v=1772587219369 "A chart showing analyst consensus forecasts for the expected stock price. INVO (INVO Bioscience Inc.)")
The difference between the consensus estimate and the actual stock price INVO (INVO Bioscience Inc.)
INVO Bioscience is "simplified" IVF. The company developed the INVOcell device, which allows for embryo incubation *inside* the body, making the procedure more accessible. This chart measures the gap between the current price and the consensus target price. It shows whether experts believe this "disruptive" technology will impact the fertility treatment market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-INVO-INVO-Bioscience-Inc.&v=1772587219444 "A chart showing the difference between the consensus forecast and the actual stock price. INVO (INVO Bioscience Inc.)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
INVO Bioscience (INVO) is a pioneer in affordable fertility treatments. Its INVOcell device is a small, in-the-body incubator that makes IVF simpler and less expensive. This chart reflects the collective opinion of the entire specialized MedTech sector. It shows whether experts believe in the growth of affordable fertility solutions.
Analysts' consensus forecast for the overall market share price
INVO Bioscience is a medical company that has developed a device (INVOcell) that makes IVF more accessible. This sector represents optional but expensive medical services. This chart reflects overall market sentiment. For INVO, whose business involves expensive discretionary spending, the overall optimism (the rising chart) is important as it reflects consumer confidence.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index INVO Bioscience Inc.
INVO is IVF in a box. Their key feature isn't R&D; their key feature is the INVOcell: a patented device (capsule) that allows the key stage of IVF (incubation) to be performed not in a test tube (laboratory), but inside a woman's body. This chart summarizes their implementation history. It reflects their (very slow) sales growth and their (uphill) battle for acceptance.
AKIMA Market Segment Index - Specialized medical equipment
INVO Bioscience offers affordable IVF. Their INVOcell device allows for part of the fertilization process to be performed inside the body, making the procedure simpler and less expensive than traditional methods. This specialized medical equipment compares their composite index to the sector, showing how their IVF solution outperforms the competition.
The AKIM Index for the overall market
INVO Bioscience is a medtech company offering INVOcell, a device for intravaginal embryo culture (an alternative to IVF). It merged with NAYA Biosciences. This chart, reflecting the market average, is just a backdrop. It helps assess how this affordable fertility story compares to overall macroeconomic trends.
